Acantholytic Pityriasis Rubra Pilaris Associated with Imiquimod 3.75% Application
Imiquimod is an immunomodulator with both antitumor and antiviral properties. It is currently available in two cream formulations as Aldara (imiquimod 5%) and the newly approved Zyclara (imiquimod 3.75%). Imiquimod has been associated with localized erythema, crusting, and scaling at the site of app...
| 主要な著者: | , , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
Hindawi Limited
2011-01-01
|
| シリーズ: | Case Reports in Dermatological Medicine |
| オンライン･アクセス: | http://dx.doi.org/10.1155/2011/412684 |